| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 21.89B | 22.08B | 24.08B | 21.08B | 20.21B | 15.37B |
| Gross Profit | 3.79B | 3.29B | 3.39B | 3.26B | 3.19B | 3.21B |
| EBITDA | -25.08M | -971.80M | 2.04B | 1.92B | 2.17B | 1.90B |
| Net Income | -6.16B | -6.56B | 95.52M | 101.60M | 1.32B | 840.91M |
Balance Sheet | ||||||
| Total Assets | 38.64B | 37.71B | 41.70B | 41.63B | 29.64B | 25.85B |
| Cash, Cash Equivalents and Short-Term Investments | 6.38B | 7.23B | 7.44B | 8.62B | 6.78B | 5.94B |
| Total Debt | 9.50B | 9.17B | 9.49B | 7.84B | 4.00B | 2.38B |
| Total Liabilities | 25.79B | 25.15B | 27.79B | 28.04B | 15.87B | 13.23B |
| Stockholders Equity | 8.31B | 8.40B | 10.27B | 10.48B | 13.40B | 12.22B |
Cash Flow | ||||||
| Free Cash Flow | 556.63M | -2.26B | -2.14B | -1.70B | -2.62B | 710.61M |
| Operating Cash Flow | 1.91B | -143.38M | 352.04M | 906.61M | -1.48B | 1.18B |
| Investing Cash Flow | -1.15B | -1.11B | -303.35M | -5.46B | -25.37M | 1.86B |
| Financing Cash Flow | -1.98B | -516.83M | 1.18B | 5.57B | 2.64B | -3.38B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | HK$17.06B | 12.66 | 13.39% | 3.23% | 8.72% | 12.71% | |
70 Outperform | HK$298.67B | 13.71 | 13.21% | 3.98% | 7.54% | -3.36% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
62 Neutral | HK$50.36B | 12.86 | 15.55% | 1.44% | 19.22% | 58.48% | |
58 Neutral | HK$10.69B | 7.99 | 8.82% | 2.50% | 12.91% | 76.99% | |
48 Neutral | HK$124.88B | 44.90 | 2.23% | ― | 9.33% | 60.54% | |
45 Neutral | HK$3.19B | -3.37 | -69.18% | ― | -4.88% | -860.80% |